Life Science Company News

Reset
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  PEP-Therapy

Orion Group Interim Report January–March 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Orion Oyj

Enterome to Present Clinical Data on EO2463 in B-cell Lymphoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Enterome S.A.

Nexstim Plc: Managers’ Transactions, Niemistö

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nexstim Plc

eyeDNA Therapeutics to Present 2-year Follow-up Phase I/II Data on its Investigational Gene Therapy HORA-PDE6b for Retinitis Pigmentosa at the ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Coave Therapeutics

MEDIROM Healthcare Technologies Inc. Announces March 2024 Key Performance Indicators (KPIs)

Read more ››
By: GlobeNewswire - 25 Apr 2024

Nexstim Plc: Managers’ Transactions, Weckroth

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nexstim Plc

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  PRISM BioLab Co.,Ltd

GSK Advocates Importance of Adult Immunisation amongst Malaysians

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicine

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Hyundai Bioscience Co. Ltd

Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Perrigo Company plc.

Zest Dental Solutions and The Pathway join forces to elevate continuing education in restorative dentistry.

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  West Pharmaceutical Services, Inc.

Indivior Announces Q1 2024 Financial Results

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Sentrycs Now Part of the UK National Protective Security Authority Catalog of Security Equipment

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024

Essity's Interim Report, Quarter 1, 2024

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Essity AB (publ)

Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Sedana Medical AB (publ)

Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Swedish Orphan Biovitrum AB (publ)

4 university colleges in Denmark join forces to enhance on-site and remote education for radiographers with Sectra Education Portal

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Sectra AB
Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »